Skip to content
Clinical Trials – home
Research site

Specijalna Bolnica Za Medicinsku Rehabilitaciju Krapinske Toplice

Croatia Ulica Ljudevita Gaja 2, 49217 Krapinske Toplice, Croatia

  • 8 trials recruiting
  • Type 2 diabetes mellitus · Arteriosclerosis · Obesity
  • Adult patients

About Specializations

Specijalna Bolnica Za Medicinsku Rehabilitaciju Krapinske Toplice in Krapinske Toplice, Croatia specialises in clinical trials of conditions such as Type 2 diabetes mellitus, Arteriosclerosis, Obesity, Overweight, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At Specijalna Bolnica Za Medicinsku Rehabilitaciju Krapinske Toplice, most trials focus on cardiovascular disease, especially conditions such as acute coronary syndrome, atrial fibrillation, heart failure, and atherosclerotic cardiovascular disease. The research is aimed at testing new treatments and improving prevention of serious events like heart attack, stroke, and cardiovascular death.

  • Preventing major cardiovascular events in people at high risk
  • Improving protection against stroke and embolism in atrial fibrillation
  • Evaluating therapies for heart failure, cardiomyopathy, and post-infarction care
  • Studying approaches to lower cardiovascular risk in patients with established vascular disease

This work reflects a strong clinical interest in both long-term risk reduction and urgent care for patients with complex heart and blood vessel conditions.

Nutritional and Metabolic Diseases

The site also conducts trials in nutritional and metabolic disease, with research centered on type 2 diabetes, overweight, obesity, and lipid disorders such as severe hypertriglyceridemia. These studies are designed to assess new therapies that may improve blood sugar control, support weight loss, and reduce metabolic and cardiovascular complications.

  • Testing treatments for better glucose control in type 2 diabetes
  • Evaluating therapies for weight reduction in overweight and obesity
  • Studying options for severe hypertriglyceridemia and related risk
  • Exploring treatments that link metabolic health with cardiovascular prevention

The research profile at this hospital shows a clear connection between metabolic care and heart health, with many studies aiming to improve outcomes for patients who have more than one chronic condition.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulica Ljudevita Gaja 249217 Krapinske TopliceCroatia
Recruiting now
8 trials
Conditions studied
13

More sites in Krapinske TopliceCroatia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

18 clinical trials

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center
Countries:CroatiaCroatia
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center
Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Sotagliflozin
  • Sponsor:Lexicon Pharmaceuticals Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Arteriosclerosis

Not recruiting
Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.